Envista Holdings (NVST) Capital Expenditures (2018 - 2026)
Envista Holdings (NVST) posted quarterly Capital Expenditures of $12.5 million for Q2 2026, up 111.86% year-over-year from $5.9 million in Q2 2025, and down 23.31% quarter-over-quarter from $16.3 million in Q4 2025.
Envista Holdings (NVST) Capital Expenditures (2018 - 2026) Analysis & Trends
Envista Holdings' Capital Expenditures history runs 9 years deep, the most recent figure standing at $12.5 million for Q2 2026.
- In Q2 2026, Capital Expenditures rose 111.86% year-over-year to $12.5 million; the TTM figure through Apr 2026 stood at $51.9 million (up 80.84% YoY), while the FY2025 annual figure was $45.3 million, up 34.02% from the prior year.
- Capital Expenditures for Q2 2026 stood at $12.5 million, down from $16.3 million in the prior quarter.
- The five-year high for Capital Expenditures was $26.9 million in Q3 2022, with the low at $5.9 million in Q1 2025.
- The 5-year median for Capital Expenditures is $12.3 million (2025), against an average of $13.3 million.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 138.55% in 2022, then tumbled 59.78% in 2024.
- Envista Holdings' Capital Expenditures stood at $16.9 million in 2022, then plunged by 51.48% to $8.2 million in 2023, then advanced by 4.88% to $8.6 million in 2024, then soared by 89.53% to $16.3 million in 2025, then retreated by 23.31% to $12.5 million in 2026.
- Business Quant data shows NVST's Capital Expenditures at $12.5 million in Q2 2026, $16.3 million in Q4 2025, and $10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.32 Bn | 129.10 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.44 Bn | 51.58 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.73 Bn | 34.38 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.08 Bn | 26.41 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.80 Bn | 14.66 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Envista Holdings | 4.38 Bn | 3.25 Bn | 407.00 Mn | 14.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 14.90 Mn |
| Jul 3, 2026 | 14.90 Mn |
| Apr 3, 2026 | 12.50 Mn |
| Apr 3, 2026 | 12.50 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Sep 26, 2025 | 10.80 Mn |
| Sep 26, 2025 | 10.80 Mn |
| Jun 27, 2025 | 12.30 Mn |
| Jun 27, 2025 | 12.30 Mn |
| Mar 28, 2025 | 5.90 Mn |
| Mar 28, 2025 | 5.90 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Sep 27, 2024 | 7.40 Mn |
| Sep 27, 2024 | 7.40 Mn |
| Jun 28, 2024 | 6.80 Mn |
| Jun 28, 2024 | 6.80 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Mar 29, 2024 | 11.00 Mn |